Skip to main content
. 2018 Dec 12;108(6):1249–1258. doi: 10.1093/ajcn/nqy274

FIGURE 3.

FIGURE 3

Post-treatment plasma vitamin D metabolite concentrations calculated by a linear model. Concentrations were adjusted for age, sex, baseline BMI, eGFR, total 25(OH)D, and blood collection season among 87 participants randomly assigned to the magnesium treatment arm and 93 participants randomly assigned to the placebo arm. The solid curves represent point estimates and the gray regions represent 95% CIs. (A) Adjusted to 25(OH)D3 = 31.37 ng/mL, age = 60 y, sex = female, BMI (kg/m2) = 29.1, baseline GFR = 78 · min−1 · 1.73 m–2, blood sample collection season = summer. (B) Adjusted to 25(OH)D3 = 3.095 ng/mL, age = 60 y, sex = female, BMI = 29.1, baseline GFR = 78 · min–1 · 1.73 m–2, blood sample collection season = summer. (C) Adjusted to 25(OH)D2 = 0.485 ng/mL, age = 60 y, sex = female, BMI = 29.1, baseline GFR = 78 · min–1 · 1.73 m–2, blood sample collection season = summer. eGFR, estimated glomerular filtration rate; GFR, glomerular filtration rate; Mag, magnesium; 25(OH)D, 25-hydroxyvitamin D; 25(OH)D2, 25-hydroxyvitamin D2; 25(OH)D3, 25-hydroxyvitamin D3; 24,25(OH)2D3, 24,25-dihydroxyvitamin D3.